Intermittent calcitriol therapy in secondary hyperparathyroidism: A comparison between oral and intraperitoneal administration

Kidney International

Volumn 54, Issue 3, 1998, Pages 907-914

  Salusky, I B ^a   Kuizon, B D ^a   Belin, T R ^a   Ramirez, J A ^a   Gales, B ^a   Segre, G V ^a   Goodman, W G ^a  

^a UCLA MEDICAL CENTER   (United States)

Author keywords

Bone histology; Dialyzed children; End stage renal disease; Mineral metabolism; Parathyroid hormone; Peritoneal dialysis; Skeletal lesion

Indexed keywords

ALKALINE PHOSPHATASE; CALCITRIOL; CALCIUM ION; PARATHYROID HORMONE; PHOSPHORUS;

ADOLESCENT; ARTICLE; BLOOD CHEMISTRY; BONE BIOPSY; BONE LESION; CALCITONIN BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; FEMALE; HISTOLOGY; HORMONE BLOOD LEVEL; HUMAN; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PERITONEAL DIALYSIS; PHOSPHATE METABOLISM; PRIORITY JOURNAL; SCHOOL CHILD; SECONDARY HYPERPARATHYROIDISM; TREATMENT OUTCOME;

EID: 0031684403     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00045.x     Document Type: Article

References (32)

1. B.A. Warady D. Hebert E.K. Sullivan S.R. Alexander A. Tejani Renal transplantation, chronic dialysis, and chronic renal insufficiency in children and adolescents. The 1995 Annual Report of the North American Pediatric Renal Transplant Cooperative Study Pediatr Nephrol 11 1997 49 64
2. I.B. Salusky J.W. Coburn J. Brill J. Foley E. Slatopolsky R.N. Fine W.G. Goodman Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD Kidney Int 33 1988 975 982
3. I.B. Salusky J.A. Ramirez W.L. Oppenheim B. Gales G.V. Segre W.G. Goodman Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPD Kidney Int 45 1994 253 258
4. W.G. Goodman I.B. Salusky Evolution of secondary hyperparathyroidism during daily oral calcitriol therapy in pediatric renal osteodystrophy Contrib Nephrol 90 1991 189 195
5. R.S. Mathias I.B. Salusky W.H. Harmon A. Paredes J. Emans G.V. Segre W.G. Goodman Renal bone disease in pediatric patients and young adults treated by hemodialysis in a childrens hospital J Am Soc Nephrol 12 1993 1938 1946
6. G. Klaus O. Mehls J. Hinderer E. Ritz Is intermittent oral calcitriol safe and effective in renal secondary hyperparathyroidism? Lancet 337 1991 800 801
7. W.G. Goodman J.A. Ramirez T.R. Belin Y. Chon B. Gales G.V. Segre I.B. Salusky Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy Kidney Int 46 1994 1160 1166
8. E. Slatopolsky C. Weerts J. Thielan R.L. Horst H. Harter K.J. Martin Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxycholecalciferol in uremic patients J Clin Invest 74 1984 2136 2143
9. L.D. Quarles D.A. Yohay B.A. Carroll C.E. Spritzer S.A. Minda D. Bartholomay B.A. Lobaugh Prospective trial of pulse oral versus intravenous calcitriol treatment of hyperparathyroidism in ESRD Kidney Int 45 1994 1710 1721
10. F. Cano A. Delucchi E. Wolff E. Rodriguez A. Fuentes Calcitriol oral pulse therapy in children with renal osteodystrophy Pediatr Nephrol 9 1995 606 608
11. J.A. Delmez C.S. Dougan B.K. Gearing M. Rothstein D.W. Windus N. Rapp E. Slatopolsky The effects of intraperitoneal calcitriol on calcium and parathyroid hormone Kidney Int 31 1987 795 799
12. A.M. Parfitt M.K. Drezner F.H. Glorieux J.A. Kanis H.H. Malluche P.J. Meunier S.M. Ott R.R. Recker Bone histomorphometry: Standardization of nomenclature, symbols, amd units J Bone Miner Res 2 1987 595 610
13. I.B. Salusky R.N. Fine P. Nelson M.J. Blumenkrantz J.D. Kopple Nutritional status of children undergoing continuous ambulatory peritoneal dialysis Am J Clin Nutr 38 1983 599 611
14. I.B. Salusky J.S. Adams R. Horst M. Holloway J.W. Coburn W.G. Goodman Enhanced calcitriol delivery after intraperitoneal administration Kidney Int 35 1989 244 abstract
15. I.B. Salusky J. Foley P. Nelson W.G. Goodman Aluminum accumulation during treatment with aluminum hydroxide and dialysis in children and young adults with chronic renal disease N Engl J Med 324 1991 527 531
16. W.G. Goodman T. Belin B. Gales H. Jüppner G.V. Segre I.B. Salusky Calcium-regulated parathyroid hormone release in patients with mild or advanced secondary hyperparathyroidism Kidney Int 48 1995 1553 1558
17. S.R. Nussbaum R.J. Zahradnik J.R. Lavigne G.L. Brennan C. Nozawa-Ung L.Y. Kim T. Keutmann C.A. Wang J.T. Potts Jr G.V. Segre Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia Clin Chem 33 1987 1364 1367
18. T.A. Reinhardt R.L. Horst J.W. Orf B.W. Hollis A microassay for 1,25 dihydroxyvitamin D not requiring high performance liquid chromatography J Clin Endocrinol Metab 58 1984 91 98
19. W.J. Dixon F.J. Massey Introduction to Statistical Analysis 4th ed 1983 McGraw Hill Book Co. New York
20. D.L. Andress K.C. Norris J.W. Coburn E.A. Slatopolsky D.J. Sherrard Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure N Engl J Med 321 1989 274 279
21. E. Slatopolsky S. Caglar J.P. Pennell D.B. Taggart J.M. Canterbury E. Reiss N.S. Bricker On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog J Clin Invest 50 1971 492 499
22. R. Kilav J. Silver T. Naveh-Many Parathyroid hormone gene expression in hypophosphatemic rats J Clin Invest 96 1995 327 333
23. E. Slatopolsky J. Finch M. Denda C. Ritter M. Zhong A. Dusso P.N. MacDonald A.J. Brown Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro J Clin Invest 97 1996 2534 2540
24. 2+ receptor-stimulated hormone release from sheep thyroid parafollicular cells J Physiol (Lond) 502 1997 31 44
25. J.W. Coburn J.D. Kopple A.S. Brickman Study of intestinal absorption of calcium in patients with renal failure Kidney Int 3 1973 264 272
26. I.B. Salusky W.G. Goodman R. Horst G.V. Segre L. Kim K.C. Norris J.S. Adams M. Holloway R.N. Fine J.W. Coburn Pharmakokinetics of calcitriol in CAPD/CCPD patients Am J Kidney Dis 16 1990 126 132
27. M.E. Cohen-Solal J.L. Sebert B. Boudailliez A. Marie P. Moriniere J. Gueris R. Bouillon A. Fournier Comparison of intact, midregion, and carboxy-terminal assays of parathyroid hormone for the diagnosis of bone disease in hemodialyzed patients J Clin Endocrinol Metab 73 1991 516 524
28. L.D. Quarles B. Lobaugh G. Murphy Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia J Clin Endocrinol Metab 75 1992 145 150
29. M. Wang G. Hercz D.J. Sherrard N.A. Maloney G.V. Segre Y. Pei Relationship between intact 1–84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity Am J Kidney Dis 26 1995 836 844
30. Q. Qi M.C. Monier-Faugere Z. Geng H.H. Malluche Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis Am J Kidney Dis 26 1995 622 631
31. A. Seidel P. Herrmann G. Klaus O. Mehls H. Schmidt-Gayk E. Ritz Kinetics of serum 1,84 iPTH after high doses of calcitriol in uremic patients Clin Nephrol 39 1993 210 213
32. B.D. Kuizon W.G. Goodman H. Jüppner I. Boechat P. Nelson B. Gales I.B. Salusky Dimninished linear growth during treatment with intermittent calcitriol and dialysis in children with chronic renal failure Kidney Int 53 1998 205 211